Sign in

Diana Glassman

About Diana Glassman

Independent Class II Director since September 2022 (age 58). Director-Engagement at EOS at Federated Hermes Limited since December 2019; prior CEO of Integration Strategy, Inc. (2014–2019). Education: BS Biology magna cum laude (Yale), MPA International Development (Harvard Kennedy School), MBA (Harvard Business School). Tenure on HLX board: 3 years as of proxy date; affirmed independent under NYSE Rule 303A .

Past Roles

OrganizationRoleTenureCommittees/Impact
Integration Strategy, Inc.Chief Executive OfficerJul 2014–Dec 2019Strategy consulting for energy/infrastructure; M&A and integration focus
TD Bank GroupRoles of increasing responsibilityNot disclosedFinancial services/ESG exposure (years not specified)
Credit SuisseRoles of increasing responsibilityNot disclosedInvestment analysis; energy sector exposure
Private equity firm & global oilfield services portfolio companyExecutive rolesNot disclosedEnergy services operations; M&A integration
PwCPositions of increasing responsibilityNot disclosedGovernance, risk and controls exposure

External Roles

OrganizationRoleTenureScope/Impact
EOS at Federated Hermes LimitedDirector-EngagementDec 2019–presentLeads Oil & Gas, co-leads Technology sector engagements and Board Effectiveness thematic; focus on strategy, risk management, capital allocation, governance, sustainability

Board Governance

  • Independence: Board determined Glassman is independent; 86% of HLX board independent; all standing committees composed of independent directors .
  • Committee assignments: Audit Committee member; Corporate Governance & Nominating Committee member .
  • Attendance: Board held 15 meetings in 2024; each director attended ≥75% of board and committee meetings; Audit (6), Compensation (4), Governance (4) meetings held .
  • Executive sessions: Non-management directors meet in executive sessions after board/committee meetings; independent Chairman presides .

Fixed Compensation

ComponentAmountNotes
2024 Fees Earned or Paid in Cash$112,500Includes Q4’23 fees paid in 2024 per reporting convention . Footnote clarifies Q4’23 fees amounts included ($22,500 for Glassman) .
Annual Director Retainer (structure)$70,000Paid quarterly; directors may elect stock in lieu of cash; election yields 125% of cash equivalent in restricted stock, vests in 2 years .
Committee Member Retainer (structure)$10,000 per committeePaid quarterly; Audit and Governance memberships apply to Glassman .
Meeting feesNot disclosedCompensation program comprises retainers and annual equity; no specific per-meeting fee disclosure .

Performance Compensation

AwardGrant DateSharesGrant-Date Fair ValueVesting/Terms
Annual Restricted Stock (for 2024 service)Dec 6, 202317,007$150,000Annual director grant; one-year vest .
Annual Restricted Stock (for future service)Dec 11, 202414,881$150,000Annual director grant; one-year vest .
Retainers taken in stock (if elected)Quarterly (following service)N/A125% of cash equivalentStock award equals 125% of cash retainers; vests 2 years after first day of grant year .
Change-in-Control provisionN/AN/AN/ADirector restricted stock subject to immediate vesting on Change in Control under 2005 LTIP .

No performance-contingent (PSU/option) compensation is disclosed for directors; equity awards are time-based restricted stock only .

Other Directorships & Interlocks

CategoryDisclosure
Current public company boardsNone disclosed for Glassman in HLX proxy .
Private/non-profit/academic boardsNot disclosed in HLX proxy .
Interlocks/shared directorshipsNot disclosed; Compensation Committee interlocks: none in 2024 .

Expertise & Qualifications

  • Strategy, energy transition, risk management, corporate governance, M&A, merger integration; experience across global energy and technology intersections including AI .
  • Education: Yale BS Biology magna cum laude; Harvard Kennedy School MPA; Harvard Business School MBA .
  • Board effectiveness engagement leadership (EOS) complements HLX Governance and Audit committee roles .

Equity Ownership

MetricValue
Total beneficial ownership (Mar 18, 2025)41,014 shares; includes unvested restricted stock with voting power .
Ownership as % of outstanding* (<1%) .
Unvested restricted stock outstanding (Dec 31, 2024)14,881 shares .
Vested/owned (beneficial less unvested)26,133 shares (41,014 − 14,881) .
Shares pledged as collateralNone; HLX prohibits hedging and tightly limits pledging; no outstanding pledges by any directors/officers .
Stock ownership guidelinesGuidelines apply to independent directors; all covered persons in compliance as of Dec 31, 2024 .

Governance Assessment

  • Strengths: Independent director with dual committee roles (Audit; Governance), solid attendance, and active involvement in EOS-led board effectiveness themes; HLX discloses robust clawback policies for executives, hedging prohibition, and strict pledging limits with no pledges outstanding—reduces alignment risk .
  • Alignment: Receives annual equity grants and may take retainers in stock; holds 41,014 shares including unvested restricted stock—modest stake but consistent with HLX’s director ownership guidelines (in compliance) .
  • Conflicts: Audit Committee oversees related-party transactions; HLX reports no related-party transactions in 2024 and no family relationships among directors/executives—low conflict signal .
  • Pay structure: Director compensation is balanced (cash + time-based equity) with immediate vesting on change-in-control (common, but accelerations can be viewed as shareholder-unfriendly by some investors) .
  • Board signals: 86% independent board; all standing committees independent; non-management executive sessions led by independent Chair support oversight effectiveness; investor support evidenced by 95% favorable Say-on-Pay in 2024 (for NEOs), indicating generally positive governance sentiment .